1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow Low-dose methotrexate (MTX): new trials by email Literature Review of Low-dose methotrexate (MTX) trials Research Report on Low-dose methotrexate (MTX)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Ruxolitinib vs Best Available Therapy (BAT) in Patients With Steroid-refractory Chronic Graft vs. Host Disease (GvHD) After Bone Marrow Transplantation (REACH3) Ruxolitinib, Extracorporeal photopheresis (ECP), Low-dose methotrexate (MTX) - Graft-versus-host Disease (GVHD) | Phase 3 | Completed | Incyte Corporation | 330 | 2017-06-29 | 2025-08-12 |
Bronchiolitis Obliterans Syndrome (1) · Graft vs Host Disease (1)
Australia (1) · Austria (1) · Belgium (1) · Bulgaria (1) · Canada (1) · Czechia (1) · Denmark (1) · France (1) · Germany (1) · Greece (1) · Hungary (1) · India (1) · Israel (1) · Italy (1) · Japan (1)
PMID 29316837, PMID 34260836, PMID 35363318, PMID 40472328, PMID 40561385, PMID 42180389
2016 (1)